Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-26-000259
Filing Date
2026-01-02
Accepted
2026-01-02 18:19:44
Documents
1
Period of Report
2025-12-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2534323-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2534323-1_3seq1.xml 3 3885
  Complete submission text file 0001104659-26-000259.txt   6227
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Issuer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 850 NEW BURTON ROAD SUITE 201 DOVER DE 19904
Business Address 850 NEW BURTON ROAD SUITE 201 DOVER DE 19904 201-240-2647
UGS Capital LLC (Reporting) CIK: 0002079932 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40598 | Film No.: 26503372

Mailing Address 2578 BROADWAY #593 NEW YORK NY 10025
Business Address 2578 BROADWAY #593 NEW YORK NY 10025 808-868-5193
Athanor Capital (Reporting) CIK: 0002101709 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40598 | Film No.: 26503373